BCL2L11 and acute lymphoblastic leukemia: Reduced accessibility of the intronic BIM locus in GC-resistant ALL samples was associated with increased levels of DNA methylation and histone acetylation, which could be reversed by DNA demethylating drug azacitidine and histone deacetylase (HDAC) inhibitor vorinostat, respectively[120,190].